Team Beachbody
November 25, 2022
The Beachbody Company said it received a deficiency letter from the New York Stock Exchange on November 23, 2022, notifying it that it was not in compliance with continued listing standards because the average closing price of its Class A common stock had been below 1 dollar over 30 consecutive trading days as of November 22.
The notice has no immediate effect on the listing. Beachbody has six months to regain compliance and said it will notify the exchange of its intent to cure the deficiency. The company said it will consider alternatives, including a reverse stock split subject to shareholder approval no later than its next annual meeting, if needed.
The company's shares continue to trade on the NYSE under the symbol BODY during the cure period.